Tacrolimus-Based versus Cyclosporine-Based Immunosuppression in Hepatitis C Virus-Infected Patients after Liver Transplantation: A Meta-Analysis and Systematic Review

BACKGROUND: Most liver transplant recipients receive calcineurin inhibitors (CNIs), especially tacrolimus and cyclosporine, as immunosuppressant agents to prevent rejection. A controversy exists as to whether the outcomes of hepatitis C virus (HCV)-infected liver transplant patients differ based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhenmin, Chen, Yi, Tao, Renchuan, Xv, Jing, Meng, Jianyuan, Yong, Xiangzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157850/
https://www.ncbi.nlm.nih.gov/pubmed/25198195
http://dx.doi.org/10.1371/journal.pone.0107057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157850/
https://www.ncbi.nlm.nih.gov/pubmed/25198195
http://dx.doi.org/10.1371/journal.pone.0107057

Ejemplares similares